Fundraising Fox

FIRE1

Dublin, IE · Founded 2014 · 110 employees on LinkedIn · 5 known investors

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.

Digital HealthHardwareMedical Devices

Investors · 5

Andera PartnersParis
Lightstone VenturesPortola Valley
Longitude CapitalMenlo Park · $10M – $30M
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Vensana CapitalreportedMinneapolis

In the news

FIRE1 Raises $120M to Transform Heart Failure Careitdigest.com · Jan 2025FIRE1 Secures $120M Financingfinsmes.com · Jan 2025FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Carebusinesswire.com · Jan 2025Novo, Medtronic join heart sensor maker FIRE1’s $25M fundingfiercebiotech.com · Mar 2023FIRE1 Raises Series A Funding - FinSMEsfinsmes.com · Jan 2014

Frequently asked questions

What does FIRE1 do?
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care. The company runs clinical trials across Europe and the US for people living with heart failure.
Who are FIRE1's investors?
FIRE1's investors include Andera Partners, Lightstone Ventures, Longitude Capital, New Enterprise Associates (NEA), Vensana Capital.
Where is FIRE1 headquartered?
FIRE1 is headquartered in Dublin, IE.